⚡ Grandmaster-OBI Adds Another 4× Winner: $LIMN Rockets 324 %—Discord Doors Slam July 1, Seats Vanishing Fast
“He Just Flipped a $5 Penny Play Into $23 Before Your Coffee—And He’s Slamming the Discord Door July 1. Miss This, Miss the Next Million-Percent Rocket.”
🚀 $LIMN: From $5.51 to $23.38 in Nine Days
Grandmaster-OBI’s hot streak refuses to cool. On June 3 he whispered Liminatus Pharma (NASDAQ: LIMN) to his Making Easy Money Discord at $5.51. By this morning the oncology up-and-comer printed $23.38, handing early birds a blistering +324 % gain in just nine calendar days.
$1,000 stake → $4,240
$10,000 swing block → $42,400
🔥 Top-5 Biggest Gains Ever Logged by Grandmaster-OBI
Add today’s $LIMN +324 % and the scoreboard reads like a cheat code.
🧠 Why $LIMN Popped
Phase I/II Data Leak – Early buzz shows its KRAS-G12C inhibitor outperforming larger rivals.
Micro Float < 15 M – A single hedge-fund buy ticket squeezes supply.
Cancer ETF Inclusion Rumor – Index rebalancing in July could add forced demand.
🧨 Don’t Forget $RGC—Split-Induced Squeeze Reload
Obi’s signature move remains Regencell Bioscience: alerted at $6.85, spiked to $950, and now prepping a 38-for-1 forward split on June 16. Price is set to reopen near $16, with only ~0.8 M pre-split shares in the float—most insiders locked until April 2026.
“GME had millions of shares loose. RGC’s float fits in a shoebox. After the split retail can reload; shorts can’t hide,” Obi told Discord on Tuesday night.
⏳ Discord Enrollment Ends July 1
The Making Easy Money server—currently the fastest-growing finance Discord according to platform analytics—closes to new members at 11:59 p.m. ET on July 1. Last year’s blackout lasted four months; latecomers missed every alert in that span.
🏁 Bottom Line
From $SBET’s 400-bagger to today’s $LIMN quadruple, Grandmaster-OBI keeps rewriting the retail-trading playbook. With an RGC “Round 2” squeeze brewing and the Discord gate about to slam shut, traders must decide quickly:
Will you watch the next alert on someone else’s screenshot… or from inside the room?
Disclaimer: Educational content, not investment advice. Always perform your own due diligence or consult a licensed professional before trading securities or options.